Page last updated: 2024-10-28

hydroxychloroquine and Foreign-Body Granuloma

hydroxychloroquine has been researched along with Foreign-Body Granuloma in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guhan, SM1
O'Connor, DM1
Gunasekera, NS1
Avram, AS1
Hoang, MP1
LaChance, AH1

Other Studies

1 other study available for hydroxychloroquine and Foreign-Body Granuloma

ArticleYear
Granuloma Formation Secondary to Surreptitiously Placed Silicone.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 06-01, Volume: 47, Issue:6

    Topics: Adalimumab; Administration, Oral; Adult; Anti-Bacterial Agents; Betamethasone; Biopsy; Body Contouri

2021